PP
AZN icon

Prudential plc’s AstraZeneca AZN Stock Holding History

Prudential plc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19B Buy
170,573
+5,510
+3% +$1.04M 17.37% 1
2026
Q1 		$3.24B Buy
+165,063
New +$31.8M 18.96% 1
2024
Q4 		– Sell
-3,155
Closed -$492K – 783
2024
Q3 		$492K Sell
3,155
-50
-2% -$8.07K ﹤0.01% 643
2024
Q2 		$500K Buy
3,205
+805
+34% +$121K ﹤0.01% 610
2024
Q1 		$325K Sell
2,400
-320
-12% -$42.4K ﹤0.01% 659
2023
Q4 		$366K Buy
+2,720
New +$354K ﹤0.01% 813

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Prudential plc's AZN Position: Q2 2026 in Review

Prudential plc increased its AstraZeneca (AZN) stake by 3.3% in Q2 2026, buying an estimated $1.04M and bringing the position to 170,573 shares worth $3.19B. The position accounts for 17.37% of the portfolio, ranked #1.

Prudential plc first reported a position in AZN in Q4 2023 and has held it in 6 quarters since. The position peaked at $3.24B in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Prudential plc held 170,573 shares of AstraZeneca worth $3.19B as of Q2 2026.
  • Prudential plc bought 5,510 AstraZeneca shares in Q2 2026, an estimated $1.04M.
  • AstraZeneca made up 17.37% of Prudential plc's portfolio in Q2 2026, its #1 holding.
  • Prudential plc first reported a position in AstraZeneca in Q4 2023 and has held it in 6 quarters since.
  • Prudential plc's AstraZeneca position peaked at $3.24B in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.